224 related articles for article (PubMed ID: 12050592)
1. [Chemical drug development].
Castro B
Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
[No Abstract] [Full Text] [Related]
2. The importance of chemistry for the future of the pharma industry.
Wild H; Heimbach D; Huwe C
Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828
[No Abstract] [Full Text] [Related]
3. Nanosuspensions in drug delivery.
Rabinow BE
Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
[TBL] [Abstract][Full Text] [Related]
4. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
5. Medicines for children: a matter of taste.
Davies EH; Tuleu C
J Pediatr; 2008 Nov; 153(5):599-604, 604.e1-2. PubMed ID: 18940350
[No Abstract] [Full Text] [Related]
6. Combinatorial chemistry at the crossroads.
Whitehead RS
Nat Biotechnol; 1998 Jan; 16(1):2-3. PubMed ID: 9447574
[No Abstract] [Full Text] [Related]
7. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
Hoffmann T; Bishop C
Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
[TBL] [Abstract][Full Text] [Related]
8. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
Fortunak J; Confalone PN; Grosso JA
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
[No Abstract] [Full Text] [Related]
9. From targets to targeted treatment solutions.
Davies N; Peakman T; Arlington S
Drug Discov Today; 2004 Mar; 9(6):245-7. PubMed ID: 15003240
[No Abstract] [Full Text] [Related]
10. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
11. Biocatalysis for pharmaceutical intermediates: the future is now.
Pollard DJ; Woodley JM
Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the reactions used for the preparation of drug candidate molecules.
Carey JS; Laffan D; Thomson C; Williams MT
Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
[TBL] [Abstract][Full Text] [Related]
13. Drug life-cycle technologies.
Fleming E; Ma P
Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
[No Abstract] [Full Text] [Related]
14. New opportunities for biocatalysis: making pharmaceutical processes greener.
Woodley JM
Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
[TBL] [Abstract][Full Text] [Related]
15. The role of medicinal chemists in drug discovery.
Greenlee WJ; Desai MC
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):419-20. PubMed ID: 16022177
[No Abstract] [Full Text] [Related]
16. Greener pharmaceuticals.
Clark JH; Breeden SW; Summerton L
Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
[No Abstract] [Full Text] [Related]
17. Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.
Bhatt PP
Expert Opin Drug Deliv; 2005 Jan; 2(1):1-2. PubMed ID: 16296731
[No Abstract] [Full Text] [Related]
18. The role of the chemical biology core facility at EMBL: a vision for a European roadmap.
Lewis JD
ACS Chem Biol; 2007 Jan; 2(1):21-3. PubMed ID: 17243779
[No Abstract] [Full Text] [Related]
19. Europe's sweeping chemical law puts medicines in peril.
Keim B
Nat Med; 2007 Jan; 13(1):4. PubMed ID: 17297677
[No Abstract] [Full Text] [Related]
20. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
